In the published article, there was an error in Table 2 as published. The prognostic biomarker hsa-miR-550a-3-5p should be corrected to hsa-miR-145-5p, and hsa-miR-4732-5p should be corrected to hsa-miR-5010-3p. The corrected Table 2 and its caption appear below.
Table 2
| miRNA | Accuracy (95% CI) | p-value |
|---|---|---|
| Diagnosis | ||
| hsa-miR-4732-5p | 1.00 (0.88–1.00) | 0 |
| hsa-miR-369-5p | 0.83 (0.65–0.94) | 0.0355 |
| hsa-miR-375 | 0.90 (0.73–0.98) | 0.0033 |
| hsa-miR-550a-3-5p | 0.90 (0.73–0.98) | 0.0033 |
| hsa-miR-145-5p | 0.93 (0.78–0.99) | 0.0007 |
| hsa-miR-5010-3p | 0.93 (0.78–0.99) | 0.0007 |
| Prognosis | ||
| hsa-miR-369-5p | 0.95 (0.74–1.00) | 0.068 |
| hsa-miR-145-5p | 0.89 (0.67–0.99) | 0.2042 |
| hsa-miR-5010-3p | 1.00 (0.82–1.00) | 0.0112 |
| hsa-miR-378c | 0.95 (0.74–1.00) | 0.068 |
| hsa-miR-1292-5p | 0.95 (0.74–1.00) | 0.068 |
Prediction power of serum exosomal miRNAs for the diagnosis and prognosis of MWoA patients.
In the published article, there was an error in Supplementary Table 1. We mistakenly used “has-miR” instead of “hsa-miR.” Therefore, we corrected Has-miR-145-5p-R and Has-miR-145-5p-F to Hsa-miR-145-5p-R and Hsa-miR-145-5p-F. The correct material statement has been updated in the original article.
In the published article, there was an error. A correction has been made to Section 3.3 Exosomal miRNA profile of HCs and MWoA patients by small RNA sequencing. The number of miRNAs consistently detected in both healthy controls and MWoA patients in section 3.3 is 388, not 338 as mentioned in the article.
The corrected sentence appears below:
“[Notably, there were 388 miRNAs consistently detected in both HCs and MWoA patients]”.
In the published article, there was an error. We mistakenly used “has-miR” instead of “hsa-miR” in our article. Therefore, we corrected all instances of “has-mir” to “hsa-mir” in the manuscript.
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
acupuncture, migraine, biomarker, exosome, miRNA
Citation
Liu L, Qi W, Wang Y, Ni X, Gao S, Zhou Z, Chen D, He Z, Sun M, Wang Z, Cai D and Zhao L (2023) Corrigendum: Circulating exosomal microRNA profiles in migraine patients receiving acupuncture treatment: a placebo-controlled clinical trial. Front. Mol. Neurosci. 16:1174810. doi: 10.3389/fnmol.2023.1174810
Received
27 February 2023
Accepted
04 April 2023
Published
20 April 2023
Volume
16 - 2023
Edited and reviewed by
Yixin Zhang, First Affiliated Hospital of Chongqing Medical University, China
Updates
Copyright
© 2023 Liu, Qi, Wang, Ni, Gao, Zhou, Chen, He, Sun, Wang, Cai and Zhao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ling Zhao zhaoling@cdutcm.edu.cnDingjun Cai djcai@cdutcm.edu.cn
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.